TreeWAS – Variant ID: rs11017328

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
L02.4 Cutaneous abscess, furuncle and carbuncle of limb	0.029	0.971	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.027	0.973	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.027	0.973	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.027	0.973	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.026	0.974	0.000
T40.2 Other opioids	0.025	0.975	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.024	0.976	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.023	0.977	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.023	0.977	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.023	0.977	0.000
T40.6 Other and unspecified narcotics	0.021	0.979	0.000
T39.0 Salicylates	0.021	0.979	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.021	0.979	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.020	0.980	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.020	0.980	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.020	0.980	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.020	0.980	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.020	0.980	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.020	0.980	0.000
T36 Poisoning by systemic antibiotics	0.020	0.980	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.020	0.980	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.019	0.980	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.019	0.981	0.000
T50.8 Diagnostic agents	0.019	0.981	0.000
T50.7 Analeptics and opioid receptor antagonists	0.019	0.981	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.019	0.981	0.000
T50.5 Appetite depressants	0.019	0.981	0.000
T50.4 Drugs affecting uric acid metabolism	0.019	0.981	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.019	0.981	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.019	0.981	0.000
T50.1 Loop [high-ceiling] diuretics	0.019	0.981	0.000
T50.0 Mineralocorticoids and their antagonists	0.019	0.981	0.000
T39.1 4-Aminophenol derivatives	0.019	0.981	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.019	0.981	0.000
T40.8 Lysergide [LSD]	0.019	0.981	0.000
T40.7 Cannabis (derivatives)	0.019	0.981	0.000
T40.5 Cocaine	0.019	0.981	0.000
T40.3 Methadone	0.019	0.981	0.000
T40.1 Heroin	0.019	0.981	0.000
T40.0 Opium	0.019	0.981	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.018	0.982	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.018	0.982	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.017	0.982	0.000
T46.1 Calcium-channel blockers	0.017	0.982	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.017	0.983	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.017	0.983	0.000
T39.4 Antirheumatics, not elsewhere classified	0.017	0.983	0.000
T39.2 Pyrazolone derivatives	0.017	0.983	0.000
T40.4 Other synthetic narcotics	0.017	0.983	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.016	0.983	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.016	0.983	0.000
T46.7 Peripheral vasodilators	0.016	0.983	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.016	0.983	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.016	0.983	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.016	0.983	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.016	0.983	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.016	0.983	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.016	0.983	0.000
T47.7 Emetics	0.016	0.983	0.000
T47.6 Antidiarrhoeal drugs	0.016	0.983	0.000
T47.5 Digestants	0.016	0.983	0.000
T47.4 Other laxatives	0.016	0.983	0.000
T47.3 Saline and osmotic laxatives	0.016	0.983	0.000
T47.2 Stimulant laxatives	0.016	0.983	0.000
T47.0 Histamine H(2)-receptor antagonists	0.016	0.983	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.016	0.984	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.016	0.984	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.016	0.984	0.000
T42.3 Barbiturates	0.016	0.984	0.000
T42.2 Succinimides and oxazolidinediones	0.016	0.984	0.000
T42.1 Iminostilbenes	0.016	0.984	0.000
T42.0 Hydantoin derivatives	0.016	0.984	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.016	0.984	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.016	0.984	0.000
J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified	0.016	0.984	0.000
T42.4 Benzodiazepines	0.015	0.984	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.015	0.985	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.015	0.985	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.015	0.985	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.015	0.985	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.015	0.985	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.015	0.985	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.015	0.985	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.015	0.985	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.015	0.985	0.000
T44.0 Anticholinesterase agents	0.015	0.985	0.000
T45.5 Anticoagulants	0.015	0.985	0.000
T38.9 Other and unspecified hormone antagonists	0.015	0.985	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.015	0.985	0.000
T38.7 Androgens and anabolic congeners	0.015	0.985	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.015	0.985	0.000
T38.5 Other oestrogens and progestogens	0.015	0.985	0.000
T38.4 Oral contraceptives	0.015	0.985	0.000
T38.2 Antithyroid drugs	0.015	0.985	0.000
T38.1 Thyroid hormones and substitutes	0.015	0.985	0.000
T38.0 Glucocorticoids and synthetic analogues	0.015	0.985	0.000
T43.9 Psychotropic drug, unspecified	0.015	0.985	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.015	0.985	0.000
T43.6 Psychostimulants with abuse potential	0.015	0.985	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.015	0.985	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.015	0.985	0.000
T36.9 Systemic antibiotic, unspecified	0.014	0.986	0.000
T36.8 Other systemic antibiotics	0.014	0.986	0.000
T36.7 Antifungal antibiotics, systemically used	0.014	0.986	0.000
T36.6 Rifamycins	0.014	0.986	0.000
T36.5 Aminoglycosides	0.014	0.986	0.000
T36.4 Tetracyclines	0.014	0.986	0.000
T36.3 Macrolides	0.014	0.986	0.000
T36.2 Chloramphenicol group	0.014	0.986	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.014	0.986	0.000
T36.0 Penicillins	0.014	0.986	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.014	0.986	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.014	0.986	0.000
T37.5 Antiviral drugs	0.014	0.986	0.000
T37.4 Anthelminthics	0.014	0.986	0.000
T37.3 Other antiprotozoal drugs	0.014	0.986	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.014	0.986	0.000
T37.1 Antimycobacterial drugs	0.014	0.986	0.000
T37.0 Sulphonamides	0.014	0.986	0.000
T41.5 Therapeutic gases	0.014	0.986	0.000
T41.4 Anaesthetic, unspecified	0.014	0.986	0.000
T41.3 Local anaesthetics	0.014	0.986	0.000
T41.2 Other and unspecified general anaesthetics	0.014	0.986	0.000
T41.1 Intravenous anaesthetics	0.014	0.986	0.000
T41.0 Inhaled anaesthetics	0.014	0.986	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.014	0.986	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.014	0.986	0.000
T48.5 Anti-common-cold drugs	0.014	0.986	0.000
T48.4 Expectorants	0.014	0.986	0.000
T48.3 Antitussives	0.014	0.986	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.014	0.986	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.014	0.986	0.000
T48.0 Oxytocic drugs	0.014	0.986	0.000
T49.9 Topical agent, unspecified	0.014	0.986	0.000
T49.8 Other topical agents	0.014	0.986	0.000
T49.7 Dental drugs, topically applied	0.014	0.986	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.014	0.986	0.000
T49.5 Ophthalmological drugs and preparations	0.014	0.986	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.014	0.986	0.000
T49.3 Emollients, demulcents and protectants	0.014	0.986	0.000
T49.2 Local astringents and local detergents	0.014	0.986	0.000
T49.1 Antipruritics	0.014	0.986	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.014	0.986	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.014	0.986	0.000
T45.8 Other primarily systemic and haematological agents	0.014	0.986	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.014	0.986	0.000
T45.6 Fibrinolysis-affecting drugs	0.014	0.986	0.000
T45.4 Iron and its compounds	0.014	0.986	0.000
T45.3 Enzymes, not elsewhere classified	0.014	0.986	0.000
T45.2 Vitamins, not elsewhere classified	0.014	0.986	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.014	0.986	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.014	0.986	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.013	0.987	0.000
T45.0 Antiallergic and antiemetic drugs	0.013	0.987	0.000
T43.2 Other and unspecified antidepressants	0.011	0.989	0.000
J44 Other chronic obstructive pulmonary disease	0.010	0.990	0.000
C18.2 Ascending colon	0.009	0.991	0.000
J44.8 Other specified chronic obstructive pulmonary disease	0.009	0.991	0.000
N03.9 Unspecified	0.009	0.991	0.000
D17.6 Benign lipomatous neoplasm of spermatic cord	0.000	0.992	0.008
D17.2 Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs	0.000	0.992	0.008
L02 Cutaneous abscess, furuncle and carbuncle	0.008	0.992	0.000
N80.3 Endometriosis of pelvic peritoneum	0.008	0.992	0.000
D17.5 Benign lipomatous neoplasm of intra-abdominal organs	0.000	0.992	0.008
D17 Benign lipomatous neoplasm	0.000	0.992	0.008
D17.0 Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck	0.000	0.992	0.008
J44.0 Chronic obstructive pulmonary disease with acute lower respiratory infection	0.007	0.993	0.000
E14.9 Without complications	0.000	0.993	0.007
L98.9 Disorder of skin and subcutaneous tissue, unspecified	0.000	0.993	0.007
E14.3 With ophthalmic complications	0.000	0.993	0.007
E14 Unspecified diabetes mellitus	0.000	0.994	0.006
L02.8 Cutaneous abscess, furuncle and carbuncle of other sites	0.006	0.994	0.000
L02.1 Cutaneous abscess, furuncle and carbuncle of neck	0.006	0.994	0.000
L02.0 Cutaneous abscess, furuncle and carbuncle of face	0.006	0.994	0.000
J44.9 Chronic obstructive pulmonary disease, unspecified	0.006	0.994	0.000
L02.3 Cutaneous abscess, furuncle and carbuncle of buttock	0.006	0.994	0.000
D17.4 Benign lipomatous neoplasm of intrathoracic organs	0.000	0.994	0.006
N03 Chronic nephritic syndrome	0.006	0.994	0.000
L02.9 Cutaneous abscess, furuncle and carbuncle, unspecified	0.005	0.994	0.000
L27.0 Generalised skin eruption due to drugs and medicaments	0.005	0.994	0.000
F43.2 Adjustment disorders	0.005	0.995	0.000
J40-J47 Chronic lower respiratory diseases	0.005	0.995	0.000
L30.9 Dermatitis, unspecified	0.005	0.995	0.000
I25.2 Old myocardial infarction	0.000	0.995	0.005
E14.8 With unspecified complications	0.000	0.995	0.005
E14.7 With multiple complications	0.000	0.995	0.005
E14.6 With other specified complications	0.000	0.995	0.005
E14.5 With peripheral circulatory complications	0.000	0.995	0.005
E14.4 With neurological complications	0.000	0.995	0.005
E14.2 Withrenal complications	0.000	0.995	0.005
E14.1 With ketoacidosis	0.000	0.995	0.005
E14.0 With coma	0.000	0.995	0.005
D17.9 Benign lipomatous neoplasm, unspecified	0.000	0.995	0.005
L27 Dermatitis due to substances taken internally	0.005	0.995	0.000
N80.9 Endometriosis, unspecified	0.005	0.995	0.000
L90.5 Scar conditions and fibrosis of skin	0.000	0.995	0.005
J43 Emphysema	0.005	0.995	0.000
H91.9 Hearing loss, unspecified	0.004	0.996	0.000
J40 Bronchitis, not specified as acute or chronic	0.004	0.996	0.000
L98 Other disorders of skin and subcutaneous tissue, not elsewhere classified	0.000	0.996	0.004
D17.3 Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites	0.000	0.996	0.004
J43.9 Emphysema, unspecified	0.004	0.996	0.000
N03.8 Other	0.004	0.996	0.000
N03.7 Diffuse crescentic glomerulonephritis	0.004	0.996	0.000
N03.6 Dense deposit disease	0.004	0.996	0.000
N03.5 Diffuse mesangiocapillary glomerulonephritis	0.004	0.996	0.000
N03.4 Diffuse endocapillary proliferative glomerulonephritis	0.004	0.996	0.000
N03.3 Diffuse mesangial proliferative glomerulonephritis	0.004	0.996	0.000
N03.2 Diffuse membranous glomerulonephritis	0.004	0.996	0.000
N03.1 Focal and segmental glomerular lesions	0.004	0.996	0.000
N03.0 Minor glomerular abnormality	0.004	0.996	0.000
S82.80 Fractures of other parts of lower leg (closed)	0.004	0.996	0.000
J45.0 Predominantly allergic asthma	0.004	0.996	0.000
L30 Other dermatitis	0.004	0.996	0.000
E10-E14 Diabetes mellitus	0.000	0.996	0.004
J45 Asthma	0.004	0.996	0.000
E10 Insulin-dependent diabetes mellitus	0.000	0.996	0.004
Z95.5 Presence of coronary angioplasty implant and graft	0.000	0.996	0.004
N80 Endometriosis	0.004	0.996	0.000
L27.1 Localised skin eruption due to drugs and medicaments	0.004	0.996	0.000
J41 Simple and mucopurulent chronic bronchitis	0.004	0.996	0.000
L20-L30 Dermatitis and eczema	0.004	0.996	0.000
D17.1 Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk	0.000	0.996	0.004
E11.3 With ophthalmic complications	0.000	0.996	0.004
D17.7 Benign lipomatous neoplasm of other sites	0.000	0.996	0.004
E11 Non-insulin-dependent diabetes mellitus	0.000	0.996	0.004
L98.4 Chronic ulcer of skin, not elsewhere classified	0.000	0.996	0.004
E10.9 Without complications	0.000	0.996	0.004
L27.9 Dermatitis due to unspecified substance taken internally	0.003	0.996	0.000
L27.8 Dermatitis due to other substances taken internally	0.003	0.996	0.000
L27.2 Dermatitis due to ingested food	0.003	0.996	0.000
J43.8 Other emphysema	0.003	0.996	0.000
J43.2 Centrilobular emphysema	0.003	0.996	0.000
J43.1 Panlobular emphysema	0.003	0.996	0.000
J43.0 MacLeod's syndrome	0.003	0.996	0.000
J42 Unspecified chronic bronchitis	0.003	0.996	0.000
L98.8 Other specified disorders of skin and subcutaneous tissue	0.000	0.996	0.004
E10.5 With peripheral circulatory complications	0.000	0.997	0.003
F43 Reaction to severe stress, and adjustment disorders	0.003	0.997	0.000
H04.1 Other disorders of lachrymal gland	0.003	0.997	0.000
N80.8 Other endometriosis	0.003	0.997	0.000
L98.7 Excessive and redundant skin and subcutaneous tissue	0.000	0.997	0.003
L98.6 Other infiltrative disorders of skin and subcutaneous tissue	0.000	0.997	0.003
L98.5 Mucinosis of skin	0.000	0.997	0.003
L98.3 Eosinophilic cellulitis [Wells]	0.000	0.997	0.003
L98.2 Febrile neutrophilic dermatosis [Sweet]	0.000	0.997	0.003
L98.1 Factitial dermatitis	0.000	0.997	0.003
E10.4 With neurological complications	0.000	0.997	0.003
F43.1 Posttraumatic stress disorder	0.003	0.997	0.000
N00-N08 Glomerular diseases	0.003	0.997	0.000
L30.5 Pityriasis alba	0.003	0.997	0.000
L30.4 Erythema intertrigo	0.003	0.997	0.000
L30.3 Infective dermatitis	0.003	0.997	0.000
L30.2 Cutaneous autosensitisation	0.003	0.997	0.000
L30.1 Dyshidrosis [pompholyx]	0.003	0.997	0.000
L30.0 Nummular dermatitis	0.003	0.997	0.000
E12 Malnutrition-related diabetes mellitus	0.000	0.997	0.003
I65.2 Occlusion and stenosis of carotid artery	0.003	0.997	0.000
J45.8 Mixed asthma	0.003	0.997	0.000
J45.1 Nonallergic asthma	0.003	0.997	0.000
E10.8 With unspecified complications	0.000	0.997	0.003
E10.7 With multiple complications	0.000	0.997	0.003
E10.6 With other specified complications	0.000	0.997	0.003
E10.2 With renal complications	0.000	0.997	0.003
E10.0 With coma	0.000	0.997	0.003
L30.8 Other specified dermatitis	0.003	0.997	0.000
E10.1 With ketoacidosis	0.000	0.997	0.003
L02.2 Cutaneous abscess, furuncle and carbuncle of trunk	0.003	0.997	0.000
N80.6 Endometriosis in cutaneous scar	0.003	0.997	0.000
N80.5 Endometriosis of intestine	0.003	0.997	0.000
N80.4 Endometriosis of rectovaginal septum and vagina	0.003	0.997	0.000
E11.2 With renal complications	0.000	0.997	0.003
L28 Lichen simplex chronicus and prurigo	0.003	0.997	0.000
L20 Atopic dermatitis	0.003	0.997	0.000
E10.3 With ophthalmic complications	0.000	0.997	0.003
J47 Bronchiectasis	0.003	0.997	0.000
L25 Unspecified contact dermatitis	0.003	0.997	0.000
L24 Irritant contact dermatitis	0.003	0.997	0.000
L23 Allergic contact dermatitis	0.003	0.997	0.000
L21 Seborrhoeic dermatitis	0.003	0.997	0.000
L26 Exfoliative dermatitis	0.003	0.997	0.000
L22 Diaper [napkin] dermatitis	0.003	0.997	0.000
J41.8 Mixed simple and mucopurulent chronic bronchitis	0.003	0.997	0.000
J41.1 Mucopurulent chronic bronchitis	0.003	0.997	0.000
J41.0 Simple chronic bronchitis	0.003	0.997	0.000
N80.2 Endometriosis of Fallopian tube	0.003	0.997	0.000
N04 Nephrotic syndrome	0.003	0.997	0.000
E11.8 With unspecified complications	0.000	0.997	0.003
E11.7 With multiple complications	0.000	0.997	0.003
E11.6 With other specified complications	0.000	0.997	0.003
E11.4 With neurological complications	0.000	0.997	0.003
E11.0 With coma	0.000	0.997	0.003
L98.0 Pyogenic granuloma	0.000	0.997	0.003
L90 Atrophic disorders of skin	0.000	0.997	0.003
N05 Unspecified nephritic syndrome	0.003	0.997	0.000
E11.1 With ketoacidosis	0.000	0.997	0.003
H04 Disorders of lachrymal system	0.003	0.997	0.000
L00-L08 Infections of the skin and subcutaneous tissue	0.003	0.997	0.000
F43.0 Acute stress reaction	0.003	0.997	0.000
E13 Other specified diabetes mellitus	0.000	0.997	0.003
L40.9 Psoriasis, unspecified	0.003	0.997	0.000
N05.2 Diffuse membranous glomerulonephritis	0.003	0.997	0.000
N02 Recurrent and persistent haematuria	0.003	0.997	0.000
F43.9 Reaction to severe stress, unspecified	0.003	0.997	0.000
F43.8 Other reactions to severe stress	0.003	0.997	0.000
H04.5 Stenosis and insufficiency of lachrymal passages	0.003	0.997	0.000
N04.9 Unspecified	0.003	0.997	0.000
H02.5 Other disorders affecting eyelid function	0.003	0.997	0.000
H04.3 Acute and unspecified inflammation of lachrymal passages	0.003	0.997	0.000
L28.1 Prurigo nodularis	0.003	0.997	0.000
J46 Status asthmaticus	0.002	0.997	0.000
H50.9 Strabismus, unspecified	0.003	0.997	0.000
N07 Hereditary nephropathy, not elsewhere classified	0.003	0.997	0.000
N06 Isolated proteinuria with specified morphological lesion	0.003	0.997	0.000
N01 Rapidly progressive nephritic syndrome	0.003	0.997	0.000
N00 Acute nephritic syndrome	0.003	0.997	0.000
E12.9 Without complications	0.000	0.997	0.002
E12.8 With unspecified complications	0.000	0.997	0.002
E12.7 With multiple complications	0.000	0.997	0.002
E12.6 With other specified complications	0.000	0.997	0.002
E12.5 With peripheral circulatory complications	0.000	0.997	0.002
E12.4 With neurological complications	0.000	0.997	0.002
E12.3 With ophthalmic complications	0.000	0.997	0.002
E12.2 With renal complications	0.000	0.997	0.002
E12.1 With ketoacidosis	0.000	0.997	0.002
E12.0 With coma	0.000	0.997	0.002
E11.5 With peripheral circulatory complications	0.000	0.997	0.003
L20.9 Atopic dermatitis, unspecified	0.002	0.997	0.000
H50.1 Divergent concomitant strabismus	0.003	0.997	0.000
N02.8 Other	0.002	0.997	0.000
H04.4 Chronic inflammation of lachrymal passages	0.002	0.997	0.000
L20.8 Other atopic dermatitis	0.002	0.997	0.000
L20.0 Besnier's prurigo	0.002	0.997	0.000
L28.2 Other prurigo	0.002	0.997	0.000
H50 Other strabismus	0.002	0.997	0.000
L21.9 Seborrhoeic dermatitis, unspecified	0.002	0.998	0.000
L21.8 Other seborrhoeic dermatitis	0.002	0.998	0.000
L21.1 Seborrhoeic infantile dermatitis	0.002	0.998	0.000
L21.0 Seborrhoea capitis	0.002	0.998	0.000
L23.9 Allergic contact dermatitis, unspecified cause	0.002	0.998	0.000
L23.8 Allergic contact dermatitis due to other agents	0.002	0.998	0.000
L23.7 Allergic contact dermatitis due to plants, except food	0.002	0.998	0.000
L23.6 Allergic contact dermatitis due to food in contact with the skin	0.002	0.998	0.000
L23.5 Allergic contact dermatitis due to other chemical products	0.002	0.998	0.000
L23.4 Allergic contact dermatitis due to dyes	0.002	0.998	0.000
L23.3 Allergic contact dermatitis due to drugs in contact with the skin	0.002	0.998	0.000
L23.2 Allergic contact dermatitis due to cosmetics	0.002	0.998	0.000
L23.1 Allergic contact dermatitis due to adhesives	0.002	0.998	0.000
L23.0 Allergic contact dermatitis due to metals	0.002	0.998	0.000
L24.9 Irritant contact dermatitis, unspecified cause	0.002	0.998	0.000
L24.8 Irritant contact dermatitis due to other agents	0.002	0.998	0.000
L24.7 Irritant contact dermatitis due to plants, except food	0.002	0.998	0.000
L24.6 Irritant contact dermatitis due to food in contact with the skin	0.002	0.998	0.000
L24.5 Irritant contact dermatitis due to other chemical products	0.002	0.998	0.000
L24.4 Irritant contact dermatitis due to drugs in contact with the skin	0.002	0.998	0.000
L24.3 Irritant contact dermatitis due to cosmetics	0.002	0.998	0.000
L24.2 Irritant contact dermatitis due to solvents	0.002	0.998	0.000
L24.1 Irritant contact dermatitis due to oils and greases	0.002	0.998	0.000
L24.0 Irritant contact dermatitis due to detergents	0.002	0.998	0.000
L25.9 Unspecified contact dermatitis, unspecified cause	0.002	0.998	0.000
L25.8 Unspecified contact dermatitis due to other agents	0.002	0.998	0.000
L25.5 Unspecified contact dermatitis due to plants, except food	0.002	0.998	0.000
L25.4 Unspecified contact dermatitis due to food in contact with the skin	0.002	0.998	0.000
L25.3 Unspecified contact dermatitis due to other chemical products	0.002	0.998	0.000
L25.2 Unspecified contact dermatitis due to dyes	0.002	0.998	0.000
L25.1 Unspecified contact dermatitis due to drugs in contact with the skin	0.002	0.998	0.000
L25.0 Unspecified contact dermatitis due to cosmetics	0.002	0.998	0.000
L40 Psoriasis	0.002	0.998	0.000
N08 Glomerular disorders in diseases classified elsewhere	0.002	0.998	0.000
H04.9 Disorder of lachrymal system, unspecified	0.002	0.998	0.000
N04.8 Other	0.002	0.998	0.000
N04.7 Diffuse crescentic glomerulonephritis	0.002	0.998	0.000
N04.6 Dense deposit disease	0.002	0.998	0.000
N04.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.998	0.000
N04.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.998	0.000
N04.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.998	0.000
N04.2 Diffuse membranous glomerulonephritis	0.002	0.998	0.000
N04.1 Focal and segmental glomerular lesions	0.002	0.998	0.000
N04.0 Minor glomerular abnormality	0.002	0.998	0.000
H04.8 Other disorders of lachrymal system	0.002	0.998	0.000
L97 Ulcer of lower limb, not elsewhere classified	0.000	0.998	0.002
L40-L45 Papulosquamous disorders	0.002	0.998	0.000
L90.9 Atrophic disorder of skin, unspecified	0.000	0.998	0.002
L90.8 Other atrophic disorders of skin	0.000	0.998	0.002
L90.6 Striae atrophicae	0.000	0.998	0.002
L90.4 Acrodermatitis chronica atrophicans	0.000	0.998	0.002
L90.3 Atrophoderma of Pasini and Pierini	0.000	0.998	0.002
L90.2 Anetoderma of Jadassohn-Pellizzari	0.000	0.998	0.002
L90.1 Anetoderma of Schweninger-Buzzi	0.000	0.998	0.002
N05.8 Other	0.002	0.998	0.000
N05.7 Diffuse crescentic glomerulonephritis	0.002	0.998	0.000
N05.6 Dense deposit disease	0.002	0.998	0.000
N05.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.998	0.000
N05.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.998	0.000
N05.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.998	0.000
N05.1 Focal and segmental glomerular lesions	0.002	0.998	0.000
N05.0 Minor glomerular abnormality	0.002	0.998	0.000
E11.9 Without complications	0.000	0.998	0.002
L05 Pilonidal cyst	0.002	0.998	0.000
N80.1 Endometriosis of ovary	0.002	0.998	0.000
L04 Acute lymphadenitis	0.002	0.998	0.000
L01 Impetigo	0.002	0.998	0.000
L00 Staphylococcal scalded skin syndrome	0.002	0.998	0.000
H04.6 Other changes in lachrymal passages	0.002	0.998	0.000
H04.0 Dacryoadenitis	0.002	0.998	0.000
M20.4 Other hammer toe(s) (acquired)	0.002	0.998	0.000
S82.8 Fractures of other parts of lower leg	0.002	0.998	0.000
Chapter XII Diseases of the skin and subcutaneous tissue	0.002	0.998	0.000
E13.8 With unspecified complications	0.000	0.998	0.002
E13.7 With multiple complications	0.000	0.998	0.002
E13.6 With other specified complications	0.000	0.998	0.002
E13.5 With peripheral circulatory complications	0.000	0.998	0.002
E13.4 With neurological complications	0.000	0.998	0.002
E13.3 With ophthalmic complications	0.000	0.998	0.002
E13.2 With renal complications	0.000	0.998	0.002
E13.1 With ketoacidosis	0.000	0.998	0.002
E13.0 With coma	0.000	0.998	0.002
H50.5 Heterophoria	0.002	0.998	0.000
L28.0 Lichen simplex chronicus	0.002	0.998	0.000
N02.7 Diffuse crescentic glomerulonephritis	0.002	0.998	0.000
N02.6 Dense deposit disease	0.002	0.998	0.000
N02.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.998	0.000
N02.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.998	0.000
N02.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.998	0.000
N02.2 Diffuse membranous glomerulonephritis	0.002	0.998	0.000
N02.1 Focal and segmental glomerular lesions	0.002	0.998	0.000
N02.0 Minor glomerular abnormality	0.002	0.998	0.000
L05.0 Pilonidal cyst with abscess	0.002	0.998	0.000
H91 Other hearing loss	0.002	0.998	0.000
Z30.5 Surveillance of (intra-uterine) contraceptive device	0.000	0.998	0.002
N00.9 Unspecified	0.002	0.998	0.000
N00.8 Other	0.002	0.998	0.000
N00.7 Diffuse crescentic glomerulonephritis	0.002	0.998	0.000
N00.6 Dense deposit disease	0.002	0.998	0.000
N00.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.998	0.000
N00.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.998	0.000
N00.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.998	0.000
N00.2 Diffuse membranous glomerulonephritis	0.002	0.998	0.000
N00.1 Focal and segmental glomerular lesions	0.002	0.998	0.000
N00.0 Minor glomerular abnormality	0.002	0.998	0.000
N01.9 Unspecified	0.002	0.998	0.000
N01.8 Other	0.002	0.998	0.000
N01.7 Diffuse crescentic glomerulonephritis	0.002	0.998	0.000
N01.6 Dense deposit disease	0.002	0.998	0.000
N01.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.998	0.000
N01.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.998	0.000
N01.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.998	0.000
N01.2 Diffuse membranous glomerulonephritis	0.002	0.998	0.000
N01.1 Focal and segmental glomerular lesions	0.002	0.998	0.000
N01.0 Minor glomerular abnormality	0.002	0.998	0.000
N06.9 Unspecified	0.002	0.998	0.000
N06.8 Other	0.002	0.998	0.000
N06.7 Diffuse crescentic glomerulonephritis	0.002	0.998	0.000
N06.6 Dense deposit disease	0.002	0.998	0.000
N06.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.998	0.000
N06.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.998	0.000
N06.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.998	0.000
N06.2 Diffuse membranous glomerulonephritis	0.002	0.998	0.000
N06.1 Focal and segmental glomerular lesions	0.002	0.998	0.000
N06.0 Minor glomerular abnormality	0.002	0.998	0.000
N07.9 Unspecified	0.002	0.998	0.000
N07.8 Other	0.002	0.998	0.000
N07.7 Diffuse crescentic glomerulonephritis	0.002	0.998	0.000
N07.6 Dense deposit disease	0.002	0.998	0.000
N07.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.998	0.000
N07.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.998	0.000
N07.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.998	0.000
N07.2 Diffuse membranous glomerulonephritis	0.002	0.998	0.000
N07.1 Focal and segmental glomerular lesions	0.002	0.998	0.000
N07.0 Minor glomerular abnormality	0.002	0.998	0.000
N05.9 Unspecified	0.002	0.998	0.000
N08.5 Glomerular disorders in systemic connective tissue disorders	0.002	0.998	0.000
H50.2 Vertical strabismus	0.002	0.998	0.000
L80-L99 Other disorders of the skin and subcutaneous tissue	0.000	0.998	0.002
C18.6 Descending colon	0.002	0.998	0.000
S42.00 Fracture of clavicle (closed)	0.002	0.998	0.000
L40.0 Psoriasis vulgaris	0.002	0.998	0.000
L43 Lichen planus	0.002	0.998	0.000
K83.1 Obstruction of bile duct	0.000	0.998	0.002
C18 Malignant neoplasm of colon	0.002	0.998	0.000
L50-L54 Urticaria and erythema	0.002	0.998	0.000
H50.8 Other specified strabismus	0.002	0.998	0.000
H50.6 Mechanical strabismus	0.002	0.998	0.000
H50.4 Other and unspecified heterotropia	0.002	0.998	0.000
H50.3 Intermittent heterotropia	0.002	0.998	0.000
N08.8 Glomerular disorders in other diseases classified elsewhere	0.002	0.998	0.000
N08.4 Glomerular disorders in other endocrine, nutritional and metabolic diseases	0.002	0.998	0.000
N08.2 Glomerular disorders in blood diseases and disorders involving the immune mechanism	0.002	0.998	0.000
N08.1 Glomerular disorders in neoplastic diseases	0.002	0.998	0.000
N08.0 Glomerular disorders in infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
Z36.3 Antenatal screening for malformations using ultrasound and other physical methods	0.000	0.998	0.002
L40.8 Other psoriasis	0.002	0.998	0.000
L40.4 Guttate psoriasis	0.002	0.998	0.000
L40.3 Pustulosis palmaris et plantaris	0.002	0.998	0.000
L40.2 Acrodermatitis continua	0.002	0.998	0.000
L40.1 Generalised pustular psoriasis	0.002	0.998	0.000
N02.9 Unspecified	0.002	0.998	0.000
D18.0 Haemangioma, any site	0.000	0.998	0.002
L44 Other papulosquamous disorders	0.002	0.998	0.000
L41 Parapsoriasis	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations